cancer 2 Flashcards

(18 cards)

1
Q
  1. Define metastasis and its clinical significance.
A

Model Answer:
Metastasis refers to the spread of malignant tumour cells from the primary site to distant tissues forming secondary implants. It is a hallmark of malignancy and the major cause of cancer-related mortality. Metastases are discontinuous with the primary tumour and confirm the tumour’s malignant nature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Describe the three main pathways of metastasis.
A

Model Answer:

Lymphatic spread: Typical of carcinomas, spreads to regional lymph nodes via lymphatic vessels.

Haematogenous spread: Common in sarcomas; tumour cells spread via blood vessels to organs like lungs, liver, brain, and bones.

Transcoelomic spread: Tumour cells spread across body cavities (e.g., peritoneal, pleural), as seen in ovarian, appendiceal, and lung cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Outline the steps of the invasion-metastasis cascade.
A

Model Answer:

Local invasion of surrounding tissue

Intravasation into blood or lymph vessels

Survival in the circulation

Extravasation at a distant site

Formation of micrometastasis

Growth into macroscopic secondary tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. What is the clonal theory of metastasis?
A

Model Answer:
The clonal theory suggests that tumours evolve through a selection of increasingly malignant subclones. These subclones acquire genetic and phenotypic changes that enhance their capacity to invade, metastasize, and resist treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. List key behavioural and biomedical risk factors for cancer.
A

Model Answer:

Behavioural: Smoking, alcohol, poor diet, physical inactivity, sun exposure

Biomedical: Obesity, diabetes

These factors contribute significantly to the cancer burden measured by DALYs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Which of the following cancers commonly spreads via transcoelomic seeding?
    A. Breast cancer
    B. Lung carcinoma
    C. Appendiceal mucinous neoplasm
    D. Renal cell carcinoma
A

Answer: C. Appendiceal mucinous neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. Which pathway of metastasis is typical for sarcomas?
    A. Lymphatic
    B. Haematogenous
    C. Transcoelomic
    D. Perineural
A

Answer: B. Haematogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. What is the most significant modifiable risk factor for cancer in Australia?
    A. Alcohol
    B. Obesity
    C. Tobacco
    D. Physical inactivity
A

Answer: C. Tobacco

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Which of the following is considered a pre-neoplastic condition?
    A. Leiomyoma
    B. Barrett’s oesophagus
    C. Lipoma
    D. Papilloma
A

Answer: B. Barrett’s oesophagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. A Krukenberg tumour is best described as:
    A. Primary ovarian adenocarcinoma
    B. Metastatic carcinoma to the ovary from the stomach
    C. Benign mucinous ovarian cyst
    D. Primary gastrointestinal lymphoma
A

Answer: B. Metastatic carcinoma to the ovary from the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Q: What confirms a tumour as malignant?

A

A: The presence of metastases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Q: Which cancers are associated with lymphatic spread?

A

A: Carcinomas, like breast and lung cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Q: What are the common sites for metastases?

A

A: Liver, lungs, bones, and brain (L2BB mnemonic).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Q: What enzymes help tumour cells degrade the ECM during metastasis?

A

A: Matrix metalloproteinases (MMPs), cathepsin D, urokinase plasminogen activator.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Q: Define pseudomyxoma peritonei.

A

A: A condition where mucinous tumour fills the peritoneal cavity, often from appendiceal neoplasms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Q: How does obesity contribute to cancer risk?

A

A: Through increased inflammation, which promotes carcinogenesis.

17
Q

Q: What is a DALY?

A

A: Disability-adjusted life year; a measure combining years lost to early death and years lived with disability.

18
Q

Q: What characterizes the clonal evolution of tumours?

A

A: The development of genetically diverse and more aggressive subclones.